
United States · Hospital & health care startup
DeepScribe is a health technology company based in San Francisco, founded in 2017.
Funding reportedLast round: Series B
DeepScribe is a health technology company based in San Francisco, founded in 2017.
It specializes in providing an ambient AI medical scribe that automates clinical documentation for healthcare providers, particularly in specialty care such as community oncology. The core product captures real-time conversations between patients and clinicians through a secure iOS app, transcribing them with proprietary AI and speech recognition technology. This generates complete, billable electronic health record (EHR) notes that integrate seamlessly into clinicians' systems. The platform functions as an "Ambient Operating System" for healthcare, offering features like AI-powered note generation, EHR integration, and clinical workflow automation. DeepScribe's services are subscription-based, targeting B2B healthcare providers, including community oncology clinics and various specialty care providers. The company aims to alleviate clinician burnout, enhance patient care, and improve revenue through automation, positioning itself as a leader in ambient AI for community oncology.
Funding, as reported
From the SEC filings it signed: 3 on the team.
On the board, as filediMichael Dyanesh Berolzheimer
What they build
Known for
health caremultilingual supportambient intelligenceelectronic health recordscomputer & network securityclinical conversation aicustomization studioprivacy and securityautomated hcc codingpatient conversationsdeepscribe assisticd-10 codinginformation technology & servicesai for complex workflowsdiagnosis capturecardiology
Built with from their website
WistiaGoogle Tag ManagerAmazon CloudFrontYouTubeGoogle WorkspaceCloudFlareViewport MetaHubspotAmazon S3MongoDB Atlas
Webflow HostingCanvas LMSApple Business ManagerGoogle MeetShareThisCloudFlare CDNReactGoogle Font API
Add your raise, your deck and your story, and put DeepScribe in front of investors. Or tell us what we have wrong.